<DOC>
	<DOCNO>NCT00906997</DOCNO>
	<brief_summary>Aims : 1 . To compare efficacy biennial immunochemical fecal occult blood test ( iFOBT ) versus colonoscopy every 10 year reduction colorectal cancer-related mortality 10 year average-risk population . 2 . To determine compliance complication associate strategy . Methods : Multicenter , randomize , control study 8 Spanish region ( Aragón , Canarias , Catalunya , Euskadi , Galicia , Madrid , Murcia Valencia ) . Study group : - Group I : iFOBT ( OC Sensor® ) one stool sample , follow colonoscopy positive result . - Group II : colonoscopy . Sample-size calculation : 27,749 subject study group ( total : 55,498 ) .</brief_summary>
	<brief_title>Colorectal Cancer Screening Average-risk Population : Immunochemical Fecal Occult Blood Testing Versus Colonoscopy</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Men woman age 5069 year Personal history colorectal cancer , colorectal adenoma , colorectal polyposis , inflammatory bowel disease Family history colorectal polyposis , Lynch syndrome familial colorectal cancer ( 2 firstdegree relative diagnose colorectal cancer one firstdegree relative diagnose colorectal cancer age 60 ) Severe comorbidity Previous total colectomy Not sign inform consent participate</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Colorectal cancer</keyword>
	<keyword>Screening</keyword>
	<keyword>Prevention</keyword>
	<keyword>Fecal occult blood test</keyword>
	<keyword>Colonoscopy</keyword>
	<keyword>Colorectal neoplasm</keyword>
	<keyword>Randomized clinical trial</keyword>
</DOC>